GlycosBio is focused on research and development to improve the delivery and performance of natural bioactive molecules to the body using our plant-based single-solution lipid absorption technologies. Located in the Johnson & Johnson Innovation Center at the Texas Medical Center, we collaborate with scientists and the medical community to design highly functional solutions for diseases where the microbiome is impaired. GlycosBio’s technologies harness the innate beneficial qualities in plant and marine lipids to provide safe and reliable personalized products.
Our Mission
Our mission is to nourish and enhance the lives of people at all stages of life with a focus on fragile populations struggling with microbiome dysbiosis. Using plant-based alternatives our scientists are working to reduce the dependence on antibiotics and prescription medication. Our vision is to modernize and elevate nutrition, skincare, and pulmonary health for all populations from infants to adults using clean technology and clinically driven results.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
What industry is GlycosBio, Inc. in?
GlycosBio, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is GlycosBio, Inc. based?
GlycosBio, Inc. is headquartered in Houston, United States.
Find investors for your startup like GlycosBio, Inc.
Gritt sends AI-personalised outreach to each investor — from your Gmail
